WuXi Biologics (Cayman) Inc.
2269
Peringkat dalam Saham
#991
Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman)... Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman) Inc. delivers a comprehensive, integrated suite of services spanning the entire biologics lifecycle, from initial discovery through development to large-scale manufacturing. The company's operations have a global footprint, serving clients across the People's Republic of China, North America, Europe, and other international regions. Its diversified offerings also include specialized consultation in biopharmaceutical technology, international sales contracting, the development and deployment of advanced testing methodologies, and robust marketing and sales support. Furthermore, WuXi Biologics is involved in providing dedicated biologics clinical and manufacturing services, the production and distribution of various medical products, contract development and manufacturing (CDMO) for vaccines and associated businesses, and acting as a supplier of key materials. The firm maintains strategic partnerships with notable entities such as ImmuneOncia Therapeutics, Legochem Biosciences Inc., Worg Pharma, OncoC4, and Exelixis Inc.
Harga Saham
$5.70
Kapitalisasi Pasar
$23.45B
Perubahan (1 hari)
-9.51%
Perubahan (1 tahun)
23.58%
Negara
CN
Perdagangan WuXi Biologics (Cayman) Inc. (2269)
Kategori
Healthcare
Margin Operasi untuk WuXi Biologics (Cayman) Inc. (2269)
Margin Operasi per 2026 TTM: 0.00%
Menurut laporan keuangan dan harga saham terbaru dari WuXi Biologics (Cayman) Inc., margin operasi saat ini (TTM) adalah 0.00%. Pada akhir 2026, margin operasi perusahaan adalah 0.00%.
Riwayat margin operasi untuk WuXi Biologics (Cayman) Inc. dari 2014 hingga 2026
Margin Operasi pada akhir setiap tahun
| Tahun | Margin Operasi | Mengubah |
|---|---|---|
| 2025 | 30.47% | 14.42% |
| 2024 | 26.63% | 1.95% |
| 2023 | 26.12% | -8.16% |
| 2022 | 28.44% | -8.20% |
| 2021 | 30.98% | 15.77% |
| 2020 | 26.76% | -3.95% |
| 2019 | 27.86% | -19.43% |
| 2018 | 34.58% | 60.54% |
| 2017 | 21.54% | 5.69% |
| 2016 | 20.38% | 82.45% |
| 2015 | 11.17% | -29.84% |
| 2014 | 15.92% | 0.00% |
Margin Operasi untuk perusahaan sejenis atau pesaing
| Perusahaan | Margin Operasi | Perbedaan Margin Operasi | Negara |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 28.81% | - |
NL
|
|
| 0.00% | - |
CH
|
Apa itu Margin Operasi perusahaan?
Margin Operasi adalah indikator utama untuk menilai profitabilitas suatu perusahaan. Margin Operasi yang lebih tinggi umumnya lebih baik karena menunjukkan bahwa perusahaan mampu menjual produk atau layanan mereka dengan harga yang jauh lebih tinggi daripada biaya produksinya. Margin Operasi dihitung dengan membagi laba perusahaan dengan pendapatannya.